Join Xaira Therapeutics as a Scientist II to lead high-quality sequencing operations and drive genomics workflows in a collaborative biotech startup.
Posted by employer 1 month ago
First seen on Joblaze 1 week ago
Last verified on the company career page 1 day ago
Skills & Technologies
Role intensity
70% hands-on coding
AI in the day-to-day
Xaira leverages AI to transform drug discovery and development, using generative AI models for designing therapeutics.
Requirements
Not disclosed in this posting: visa sponsorship.
Benefits
Joblaze summary
In the role of Scientist II at Xaira Therapeutics, the individual will focus on generating high-quality sequencing data to support the company's AI-driven drug discovery efforts. Key responsibilities include designing and optimizing next-generation sequencing workflows, particularly using Illumina platforms, while collaborating with various teams on genomics-based projects. This position is suited for an experienced scientist with a strong background in NGS library preparation and a collaborative mindset, ideally within a startup environment that emphasizes innovation and interdisciplinary work.
Joblaze insights
Quick facts
From the original posting
About Xaira Therapeutics
Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling the creation of medicines against historically hard-to-drug molecular targets. It is also developing foundation models for biology and disease to enable better target elucidation and patient stratification. Collectively, these technologies aim to continually enable the identification of novel therapies and to improve success in drug development. Xaira is headquartered in the San Francisco Bay Area, Seattle, and London.
About the Role
As a Scientist II on Xaira's Genomics Core team within the High Throughput Biology organization, you will play a key role in generating high-quality sequencing data that powers our discovery platform and AI-driven research. You will serve as a technical leader responsible for designing, developing, optimizing, and executing next-generation sequencing (NGS) workflows, with a primary focus on Illumina sequencing platforms, including MiSeq, NextSeq, and NovaSeq. You will partner closely with Functional Genomics, Disease Biology, Automation, and Computational Biology teams to develop scalable sequencing strategies that support CRISPR-based perturbation studies, single-cell genomics, and other high-throughput discovery efforts.
The ideal candidate is an experienced experimental scientist with deep expertise in NGS library preparation, Illumina sequencing operations, and 10x Genomics workflows. This is a highly collaborative, hands-on laboratory role that requires independent scientific thinking, experimental design, and technical leadership to implement new technologies and continuously improve genomics workflows across the organization.
Responsibilities
Qualifications
Preferred Qualifications
Compensation
Annual
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants. We offer a competitive package that includes base salary, bonus, and equity. The base pay range for this position is expected to be $124,000 to $155,000 annually; however, the base pay offered may vary depending on the market, job-related knowledge, skills and capabilities, and experience.
Xaira Therapeutics an equal-opportunity employer. We believe that our strength is in our differences. Our goal to build a diverse and inclusive team began on day one, and it will never end.
TO ALL RECRUITMENT AGENCIES: Xaira Therapeutics does not accept agency resumes. Please do not forward resumes to our jobs alias or employees. Xaira Therapeutics is not responsible for any fees related to unsolicited resumes.